174 related articles for article (PubMed ID: 36170582)
1. Risk factors for developing upper limb cellulitis after breast cancer treatment.
Engin O; Sahin E; Saribay E; Dilek B; Akalin E
Lymphology; 2022; 55(2):77-83. PubMed ID: 36170582
[TBL] [Abstract][Full Text] [Related]
2. [Preventive axillary lymphovenous anastomoses simultaneously with lymph node dissection in the treatment of breast cancer for prevention of lymphedema of the upper limb (LYMPHA technique)].
Ovchinnikova IV; Gimranov AM; Tazieva GR; Busygin MA; Korunova EG
Khirurgiia (Mosk); 2024; (2. Vyp. 2):42-47. PubMed ID: 38380463
[TBL] [Abstract][Full Text] [Related]
3. [Risk factors for developing upper limb lymphedema after breast cancer treatment].
Arrault M; Vignes S
Bull Cancer; 2006 Oct; 93(10):1001-6. PubMed ID: 17074659
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements.
McLaughlin SA; Wright MJ; Morris KT; Giron GL; Sampson MR; Brockway JP; Hurley KE; Riedel ER; Van Zee KJ
J Clin Oncol; 2008 Nov; 26(32):5213-9. PubMed ID: 18838709
[TBL] [Abstract][Full Text] [Related]
5. Predictors of lymphedema in patients with breast cancer undergoing axillary lymph node dissection in Hong Kong.
Mak SS; Yeo W; Lee YM; Mo KF; Tse KY; Tse SM; Ho FP; Kwan WH
Nurs Res; 2008; 57(6):416-25. PubMed ID: 19018216
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for breast cancer-related lymphedema: correlation with docetaxel administration.
Aoishi Y; Oura S; Nishiguchi H; Hirai Y; Miyasaka M; Kawaji M; Shima A; Nishimura Y
Breast Cancer; 2020 Sep; 27(5):929-937. PubMed ID: 32270417
[TBL] [Abstract][Full Text] [Related]
7. [Comparative analysis of the correlation between axillary treatment and upper limb lymphedema].
Lin Y; Xu Y; Zhang XH; Wang CJ; Sun Q
Zhonghua Wai Ke Za Zhi; 2019 Sep; 57(9):713-716. PubMed ID: 31474063
[TBL] [Abstract][Full Text] [Related]
8. The incidence and risk factors for occurrence of arm lymphedema after treatment of breast cancer.
Rebegea L; Firescu D; Dumitru M; Anghel R
Chirurgia (Bucur); 2015; 110(1):33-7. PubMed ID: 25800313
[TBL] [Abstract][Full Text] [Related]
9. Cellulitis risk factors for patients with primary or secondary lymphedema.
Vignes S; Poizeau F; Dupuy A
J Vasc Surg Venous Lymphat Disord; 2022 Jan; 10(1):179-185.e1. PubMed ID: 33957278
[TBL] [Abstract][Full Text] [Related]
10. Factors Associated With Lymphedema in Women With Node-Positive Breast Cancer Treated With Neoadjuvant Chemotherapy and Axillary Dissection.
Armer JM; Ballman KV; McCall L; Ostby PL; Zagar E; Kuerer HM; Hunt KK; Boughey JC
JAMA Surg; 2019 Sep; 154(9):800-809. PubMed ID: 31314062
[TBL] [Abstract][Full Text] [Related]
11. Cellulitis after axillary lymph node dissection for carcinoma of the breast.
Simon MS; Cody RL
Am J Med; 1992 Nov; 93(5):543-8. PubMed ID: 1364813
[TBL] [Abstract][Full Text] [Related]
12. Surgical procedures and lymphedema of the upper and lower extremity.
Karakousis CP
J Surg Oncol; 2006 Feb; 93(2):87-91. PubMed ID: 16425311
[TBL] [Abstract][Full Text] [Related]
13. Lymphedema following axillary lymph node dissection for breast cancer.
Sakorafas GH; Peros G; Cataliotti L; Vlastos G
Surg Oncol; 2006 Nov; 15(3):153-65. PubMed ID: 17187979
[TBL] [Abstract][Full Text] [Related]
14. Body mass index increases the risk of breast cancer-related lymphedema at 6-18 months after surgery: a retrospective study.
Wang L; Chen H; Li Y; Wang H; Liu N; Yu M; Shang S
Support Care Cancer; 2023 Apr; 31(5):278. PubMed ID: 37074508
[TBL] [Abstract][Full Text] [Related]
15. Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients.
Helyer LK; Varnic M; Le LW; Leong W; McCready D
Breast J; 2010; 16(1):48-54. PubMed ID: 19889169
[TBL] [Abstract][Full Text] [Related]
16. Residual lymph node disease after neoadjuvant chemotherapy predicts an increased risk of lymphedema in node-positive breast cancer patients.
Specht MC; Miller CL; Skolny MN; Jammallo LS; O'Toole J; Horick N; Isakoff SJ; Smith BL; Taghian AG
Ann Surg Oncol; 2013 Sep; 20(9):2835-41. PubMed ID: 23689935
[TBL] [Abstract][Full Text] [Related]
17. The changing role of axillary treatment in breast cancer: Who will remain at risk for developing arm morbidity in the future?
Lopez Penha TR; van Roozendaal LM; Smidt ML; Boersma LJ; von Meyenfeldt MF; Voogd AC; Heuts EM
Breast; 2015 Oct; 24(5):543-7. PubMed ID: 26051795
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors.
McLaughlin SA; Wright MJ; Morris KT; Sampson MR; Brockway JP; Hurley KE; Riedel ER; Van Zee KJ
J Clin Oncol; 2008 Nov; 26(32):5220-6. PubMed ID: 18838708
[TBL] [Abstract][Full Text] [Related]
19. Morbidity after conventional dissection of axillary lymph nodes in breast cancer patients.
Soares EW; Nagai HM; Bredt LC; da Cunha AD; Andrade RJ; Soares GV
World J Surg Oncol; 2014 Mar; 12():67. PubMed ID: 24670000
[TBL] [Abstract][Full Text] [Related]
20. Upper limb physical function and adverse effects after breast cancer surgery: a prospective 2.5-year follow-up study and preoperative measures.
Sagen A; Kaaresen R; Sandvik L; Thune I; Risberg MA
Arch Phys Med Rehabil; 2014 May; 95(5):875-81. PubMed ID: 24389401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
